Article
Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.
Pediatric nephrology (Berlin, Germany) - 1 Sept 2008
Davin Jean Claude, Strain Lisa, Goodship Tim H J
Abstract excerpt
Whilst randomised control trials are undoubtedly the best way to demonstrate whether plasma exchange or infusion alone is the best first-line treatment for patients with atypical haemolytic uremic syndrome (aHUS), individual case reports can provide valuable information. To that effect, we have had the unique opportunity to follow over a 10-year period three sisters with aHUS associated with a factor H mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
